Role of microglia in glioma biology

Microglia, a type of differentiated tissue macrophage, are considered to be the most plastic cell population of the central nervous system (CNS). In response to pathological conditions, resting microglia undergo a stereotypic activation process and become capable of phagocytosis, antigen presentation, and lymphocyte activation. Considering their immune effector function, it is not surprising to see microglia accumulation in almost every CNS disease process, including malignant brain tumors or malignant gliomas. Although the function of these cells in CNS inflammatory processes is being studied, their role in malignant glioma biology remains unclear. On one hand, microglia may represent a CNS anti‐tumor response, which is inactivated by local secretion of immunosuppressive factors by glioma cells. On the other hand, taking into account that microglia are capable of secreting a variety of immunomodulatory cytokines, it is possible that they are attracted by gliomas to promote tumor growth. A better understanding of microglia‐glioma interaction will be helpful in designing novel immune‐based therapies against these fatal tumors. Microsc. Res. Tech. 54:106–113, 2001. © 2001 Wiley‐Liss, Inc.

[1]  B. Badie,et al.  Expression of Fas ligand by microglia: possible role in glioma immune evasion , 2001, Journal of Neuroimmunology.

[2]  Becky,et al.  Dexamethasone-induced abolition of the inflammatory response in an experimental glioma model: a flow cytometry study. , 2000, Journal of neurosurgery.

[3]  I. Parney,et al.  Human glioma immunobiology in vitro: implications for immunogene therapy. , 2000, Neurosurgery.

[4]  B. Badie,et al.  Interferon-γ Induces Apoptosis and Augments the Expression of Fas and Fas Ligand by Microglia in Vitro , 2000, Experimental Neurology.

[5]  B. Badie,et al.  Flow cytometric characterization of tumor-associated macrophages in experimental gliomas. , 2000, Neurosurgery.

[6]  R. Dempsey,et al.  Traumatic Brain Injury Leads to Increased Expression of Peripheral-Type Benzodiazepine Receptors, Neuronal Death, and Activation of Astrocytes and Microglia in Rat Thalamus , 2000, Experimental Neurology.

[7]  M. Graeber,et al.  Microglia only weakly present glioma antigen to cytotoxic T cells , 1999, International Journal of Developmental Neuroscience.

[8]  P. Rieckmann,et al.  Microglial/macrophage expression of interleukin 10 in human glioblastomas , 1999, International journal of cancer.

[9]  I. Bechmann,et al.  FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: Evidence for the existence of an immunological brain barrier , 1999, Glia.

[10]  K. Frei,et al.  Treatment of experimental glioma by administration of adenoviral vectors expressing Fas ligand. , 1999, Human gene therapy.

[11]  B. Badie,et al.  In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factor. , 1999, Neurosurgery.

[12]  V. Nguyen,et al.  Class II transactivator and class II MHC gene expression in microglia: modulation by the cytokines TGF‐β, IL‐4, IL‐13 and IL‐10 , 1999, European journal of immunology.

[13]  D. Wedekind,et al.  Tumor gene therapy made easy: allogeneic major histocompatibility complex in the C6 rat glioma model. , 1999, Human gene therapy.

[14]  Charles B. Wilson,et al.  Primary central nervous system tumors: Advances in knowledge and treatment , 1998, CA: a cancer journal for clinicians.

[15]  Imai,et al.  Differential expression of MHC class II molecules by microglia and neoplastic astroglia: relevance for the escape of astrocytoma cells from immune surveillance , 1998, Neuropathology and applied neurobiology.

[16]  J. Sedgwick,et al.  Central nervous system microglial cell activation and proliferation follows direct interaction with tissue-infiltrating T cell blasts. , 1998, Journal of immunology.

[17]  E. Hudson,et al.  Met and hepatocyte growth factor/scatter factor expression in human gliomas. , 1997, Cancer research.

[18]  S. Leung,et al.  Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas , 1997, Acta Neuropathologica.

[19]  Erwin G. Van Meir,et al.  Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? , 1997, The Journal of clinical investigation.

[20]  J. Sedgwick,et al.  Microglia induce CD4 T lymphocyte final effector function and death , 1996, The Journal of experimental medicine.

[21]  W. Paulus,et al.  Distribution and characterization of microglia/macrophages in human brain tumors , 1996, Acta Neuropathologica.

[22]  S. Thanos,et al.  The concept of microglia in relation to central nervous system disease and regeneration , 1996, Progress in Neurobiology.

[23]  T. Tsukahara,et al.  Hepatocyte growth factor specifically expressed in microglia activated Ras in the neurons, similar to the action of neurotrophic factors. , 1995, Biochemical and biophysical research communications.

[24]  D. Dickson,et al.  GM‐CSF promotes proliferation of human fetal and adult microglia in primary cultures , 1994, Glia.

[25]  Erwin G. Van Meir,et al.  Human astrocytomas and glioblastomas express monocyte chemoattractant protein‐1 (MCP‐1) in vivo and in vitro , 1994, International journal of cancer.

[26]  Streit Wj.  Cellular immune response in brain tumors. , 1994 .

[27]  P. Mcgeer,et al.  Immunohistochemistry with antibodies to hepatocyte growth factor and its receptor protein (c-MET) in human brain tissues , 1994, Brain Research.

[28]  I. Kuchna,et al.  Reaction of microglial cells in human astrocytomas (preliminary report). , 1994, Folia neuropathologica.

[29]  K. Jaeckle.  Immunotherapy of malignant gliomas. , 1994, Seminars in oncology.

[30]  T. Marunouchi,et al.  Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro. , 1993, Journal of immunology.

[31]  D. Walker,et al.  Microglia in degenerative neurological disease , 1993, Glia.

[32]  E. Ling,et al.  The origin and nature of ramified and amoeboid microglia: A historical review and current concepts , 1993, Glia.

[33]  P. Comoglio,et al.  Selective expression of the Met/HGF receptor in human central nervous system microglia. , 1993, Oncogene.

[34]  K. Black,et al.  Inflammatory cell infiltrates vary in experimental primary and metastatic brain tumors. , 1992, Neurosurgery.

[35]  Erwin G. Van Meir,et al.  Granulocyte-macrophage colony-stimulating factor (GM-CSF) production by glioblastoma cells. Despite the presence of inducing signals GM-CSF is not expressed in vivo. , 1992, Journal of immunology.

[36]  V. ter meulen,et al.  Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Merrill,et al.  Natural and induced cytotoxicity of oligodendrocytes by microglia is inhibitable by TGFβ , 1991, Glia.

[38]  J. Kuratsu,et al.  Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants , 1989, The Journal of experimental medicine.

[39]  C C Chang,et al.  Immunohistological evaluation of macrophage infiltrates in brain tumors. Correlation with peritumoral edema. , 1988, Journal of neurosurgery.

[40]  K. Frei,et al.  Antigen presentation and tumor cytotoxicity by interferon‐γ‐treated microglial cells , 1987 .

[41]  S. Green,et al.  Glioblastoma multiforme and anaplastic astrocytoma pathologic criteria and prognostic implications , 1985, Cancer.

[42]  K. Gollahon,et al.  Macrophages in experimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors. , 1979, Journal of neurosurgery.

[43]  K. Gollahon,et al.  Macrophages in experimental and human brain tumors. Part 1: Studies of the macrophage content of experimental rat brain tumors of varying immunogenicity. , 1979, Journal of neurosurgery.

[44]  W. Markesbery,et al.  Relationship of lymphocyte invasion and survival of brain tumor patients , 1978, Annals of neurology.